Miranda L. Davies
Portsmouth, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
Current Challenges in Monitoring the Safety and Utilisation of the Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RAs): A UK Perspective.
Journal: Drug safety
Published: December 16, 2025
A Scoping Review of Case-Level Causality Assessment Tools Developed Between 2008 and 2023; Strengths, Weaknesses and Potential Future Improvements.
Journal: Drug safety
Published: December 04, 2025
Electronic health record data to develop indicators of end-of-life care quality.
Journal: BMJ supportive & palliative care
Published: June 20, 2025
Improving maternity provision for incarcerated women in the UK.
Journal: BMJ (Clinical research ed.)
Published: January 15, 2025
Safety and effectiveness of the anti-amyloid monoclonal antibody (mAb) drug lecanemab for early Alzheimer's disease: The pharmacovigilance perspective.
Journal: British journal of clinical pharmacology
Published: September 05, 2024
Comparing the rate of inpatient admissions of prison residents with COVID-19 to the general population in England in 2020/2021 using Hospital Episode Statistics data.
Journal: BMJ public health
Published: August 23, 2023
The International Working Group on New Developments in Pharmacovigilance: Advancing Methods and Communication in Pharmacovigilance.
Journal: Clinical therapeutics
Published: July 28, 2023
Safety of Ovaleap® (Follitropin Alfa) in Infertile Women Undergoing Superovulation for Assisted Reproductive Technologies: A Multinational Comparative, Prospective Cohort Study.
Journal: Frontiers in endocrinology
Published: November 23, 2020
How to Investigate a Serious Adverse Event Reported During a Clinical Trial for a COVID-19 Vaccine.
Journal: Drug safety
Published: November 01, 2020
Cardiovascular health within the UK prison population.
Journal: Heart (British Cardiac Society)
Published: October 20, 2020
Last Updated: 09/26/2026